FDA inspection
Recipharm Uppsala AB: FDA inspection ending Jun 30, 2017
FDA inspection 1028387 · No Action Indicated (NAI) · Uppsala
Key facts
| Inspection ID | 1028387 |
|---|---|
| Firm | Recipharm Uppsala AB |
| FEI number | 1000171246 |
| Address | Bjorkgatan 30 |
| City | Uppsala |
| Country | Sweden |
| Fiscal year | 2017 |
| Inspection end date | Jun 30, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data